Press releases
2024
5 Dec 2024, 15:30
Data from the trial is expected to be shared in 2025
3 Dec 2024, 07:00
The trial will be conducted in patients with pre-existing anti-AAV antibodies which limit use of gene therapy treatment
13 Nov 2024, 09:00
30 Oct 2024, 09:00
17 Oct 2024, 07:00 | Regulatory
Q3 2024 marks highest ever in-market quarterly sales performance and fourth consecutive quarter of strong sales performance
7 Oct 2024, 10:00
3 Oct 2024, 07:00